AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Sten-Linder, M Seddighzadeh, M Engel, G Rutqvist, LE Linder, S Skoog, L Wiman, B
Citation: M. Sten-linder et al., Prognostic importance of the uPA/PAI-1 complex in breast cancer, ANTICANC R, 21(4B), 2001, pp. 2861-2865

Authors: Wiman, B Andersson, T Hallqvist, J Reuterwall, C Ahlbom, A deFaire, U
Citation: B. Wiman et al., Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study, ART THROM V, 20(8), 2000, pp. 2019-2023

Authors: Sui, GC Wiman, B
Citation: Gc. Sui et B. Wiman, The B beta-sheet in the PAI-1 molecule plays an important role for its stability, THROMB HAEM, 83(6), 2000, pp. 896-901

Authors: Moor, E Blomback, M Silveira, A Wiman, B Cederlund, K Bergstrand, L Ivert, T Ryden, L Hamsten, A
Citation: E. Moor et al., Haemostatic function in patients undergoing coronary artery bypass grafting: Peroperative perturbations and relations to saphenous vein graft closure, THROMB RES, 98(1), 2000, pp. 39-49

Authors: Wiman, B
Citation: B. Wiman, Discovery of PAI-1 in plasma, THROMB RES, 100(1), 2000, pp. 7-8

Authors: Held, C Hjemdahl, P Wallen, NH Bjorkander, I Forslund, L Wiman, B Rehnqvist, N
Citation: C. Held et al., Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris - Results from the APSIS study, ATHEROSCLER, 148(1), 2000, pp. 179-188

Authors: Mangs, H Sui, GC Wiman, B
Citation: H. Mangs et al., PAI-1 stability: the role of histidine residues, FEBS LETTER, 475(3), 2000, pp. 192-196

Authors: Larsson, PT Wallen, NH Wiman, B Dooijewaard, G
Citation: Pt. Larsson et al., alpha- and beta-adrenergic influences on the tissue and urokinase plasminogen activator systems, FIBRINOL PR, 13(4-5), 1999, pp. 169-175

Authors: Ny, T Thorsen, S Wiman, B
Citation: T. Ny et al., Per Wallen - Obituary, FIBRINOL PR, 13(4-5), 1999, pp. 216-216

Authors: Falk, G Sui, GC Schulman, S Wiman, B
Citation: G. Falk et al., Detection of a new polymorphism in the PAI-1 gene located in the pro-peptide coding region, FIBRINOL PR, 13(1), 1999, pp. 26-30

Authors: Reuterwall, C Hallqvist, J Ahlbom, A De Faire, U Diderichsen, F Hogstedt, C Pershagen, G Theorell, T Wiman, B Wolk, A
Citation: C. Reuterwall et al., Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study, J INTERN M, 246(2), 1999, pp. 161-174

Authors: Lindmarker, P Schulman, S Sten-Linder, M Wiman, B Egberg, N Johnsson, H
Citation: P. Lindmarker et al., The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene, THROMB HAEM, 81(5), 1999, pp. 684-689

Authors: Seddighzadeh, M Zhou, JN Kronenwett, U Shoshan, MC Auer, G Sten-Linder, M Wiman, B Linder, S
Citation: M. Seddighzadeh et al., ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation, CLIN EXP M, 17(8), 1999, pp. 649-654

Authors: Sten-Linder, M Linder, C Strander, H Munck-Wikland, E Wersall, P Linder, S Wiman, B
Citation: M. Sten-linder et al., Angiostatin fragments in urine from patients with malignant disease, ANTICANC R, 19(4C), 1999, pp. 3409-3414

Authors: Sui, GC Mangs, H Wiman, B
Citation: Gc. Sui et al., The role of His(143) for the pH-dependent stability of plasminogen activator inhibitor-1, BBA-PROT ST, 1434(1), 1999, pp. 58-63

Authors: Wiman, B
Citation: B. Wiman, Predictive value of fibrinolytic factors in coronary heart disease, SC J CL INV, 59, 1999, pp. 23-31

Authors: Sartori, MT Wiman, B Vettore, S Dazzi, F Girolami, A Patrassi, GM
Citation: Mt. Sartori et al., 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis, THROMB HAEM, 80(6), 1998, pp. 956-960
Risultati: 1-17 |